Dual Targeting of Cancer Cells with DARPin-Based Toxins for Overcoming Tumor Escape; Cancers; Vol. 12, iss. 10

Dual Targeting of Cancer Cells with DARPin-Based Toxins for Overcoming Tumor Escape; Cancers; Vol. 12, iss. 10

Bibliografiske detaljer
Parent link:	Cancers Vol. 12, iss. 10.— 2020.— [3014, 15 p.]
Institution som forfatter:	Национальный исследовательский Томский политехнический университет Исследовательская школа химических и биомедицинских технологий Научно-исследовательский центр "Онкотераностика"
Andre forfattere:	Shramova E. I. Elena Ivanovna, Proshkina G. M. Galina Mikhaylovna, Shipunova V. Viktoriya, Ryabova A. Anastasiya, Kamyshinsky R. Roman, Konevega A. Andrey, Shulga (Schulga) A. A. Aleksey Anatolievich, Konovalova E. V. Elena Valerjevna, Telegin G. Georgy, Deev S. M. Sergey Mikhaylovich
Summary:	Title screen We report here a combined anti-cancer therapy directed toward HER2 and EpCAM, common tumor-associated antigens of breast cancer cells. The combined therapeutic effect is achieved owing to two highly toxic proteins—a low immunogenic variant of Pseudomonas aeruginosa exotoxin A and ribonuclease Barnase from Bacillus amyloliquefaciens. The delivery of toxins to cancer cells was carried out by targeting designed ankyrin repeat proteins (DARPins). We have shown that both target agents efficiently accumulate in the tumor. Simultaneous treatment of breast carcinoma-bearing mice with anti-EpCAM fusion toxin based on LoPE and HER2-specific liposomes loaded with Barnase leads to concurrent elimination of primary tumor and metastases. Monotherapy with anti-HER2- or anti-EpCAM-toxins did not produce a comparable effect on metastases. The proposed approach can be considered as a promising strategy for significant improvement of cancer therapy.
Sprog:	engelsk
Udgivet:	2020
Fag:	электронный ресурс труды учёных ТПУ barnase liposomes HER2 EpCAM cancer therapy липосомы противораковая активность терапия
Online adgang:	https://doi.org/10.3390/cancers12103014
Format:	Electronisk Book Chapter
KOHA link:	https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=664919

Lignende værker

Feasibility of Imaging EpCAM Expression in Ovarian Cancer Using Radiolabeled DARPin Ec1; International Journal of Molecular Sciences; Vol. 21, iss. 9
Udgivet: (2020)

Effect of a radiolabel biochemical nature on tumor-targeting properties of EpCAM-binding engineered scaffold protein DARPin Ec1; International Journal of Biological Macromolecules; Vol. 145
Udgivet: (2020)

Radionuclide Molecular Imaging of EpCAM Expression in Triple-Negative Breast Cancer Using the Scaffold Protein DARPin Ec1; Molecules; Vol. 25, iss. 20
Udgivet: (2020)

Penetration Efficiency of Antitumor Agents in Ovarian Cancer Spheroids: The Case of Recombinant Targeted Toxin DARPin-LoPE and the Chemotherapy Drug, Doxorubicin; Pharmaceutics; Vol. 11, iss. 5
Udgivet: (2019)

HER2-Specific Targeted Toxin DARPin-LoPE: Immunogenicity and Antitumor Effect on Intraperitoneal Ovarian Cancer Xenograft Model; International Journal of Molecular Sciences; Vol. 20, iss. 10
Udgivet: (2019)

Evaluating the Therapeutic Efficacy of Mono- and Bivalent Affibody-Based Fusion Proteins Targeting HER3 in a Pancreatic Cancer Xenograft Model; Pharmaceutics; Vol. 12, iss. 6
Udgivet: (2020)

Radionuclide Therapy of HER2-Expressing Xenografts Using [177Lu]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab; Cancers; Vol. 15 - iss. 9
Udgivet: (2023)

Влияние расположения ABD на таргетные свойства нового бивалентного терапевтического конъюгата на основе DARPin G3; Перспективы развития фундаментальных наук; Т. 4 : Биология и фундаментальная медицина
af: Прач А. А. Анастасия Александровна
Udgivet: (2024)

Comparison of HER2-targeted affibody conjugates loaded with auristatin- and maytansine-derived drugs; Journal of Controlled Release; Vol. 355
Udgivet: (2023)

Affibody Molecules as Targeting Vectors for PET Imaging; Cancers; Vol. 12, iss. 3
af: Tolmachev V. M. Vladimir Maksimilianovich
Udgivet: (2020)

Cancer-Targeted Drug Delivery
Udgivet: (2025)

Drug Conjugates Based on a Monovalent Affibody Targeting Vector Can Efficiently Eradicate HER2 Positive Human Tumors in an Experimental Mouse Model; Cancers; Vol. 13, iss. 1
Udgivet: (2020)

Cancer Vaccines Methods and Protocols /
Udgivet: (2025)

Handbook of Cancer and Immunology
Udgivet: (2022)

Direct Intra-Patient Comparison of Scaffold Protein-Based Tracers, [99mTc]Tc-ADAPT6 and [99mTc]Tc-(HE)3-G3, for Imaging of HER2-Positive Breast Cancer; Cancers; Vol. 15 - iss. 12
Udgivet: (2023)

Preclinical Evaluation of HER2-Targeting DARPin G3: Impact of Albumin-Binding Domain (ABD) Fusion; International Journal of Molecular Sciences; Vol. 25, iss. 8
Udgivet: (2024)

Optimal Impulsive Control for Cancer Therapy
af: Belfo, João P., et al.
Udgivet: (2021)

Phase I clinical evaluation of 99mTc-labeled Affibody molecule for imaging HER2 expression in breast cancer; Theranostics; Vol. 13, iss. 14
Udgivet: (2023)

Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
Udgivet: (2021)

Kinetic analysis of HER2-binding ABY-025 Affibody molecule using dynamic PET in patients with metastatic breast cancer; EJNMMI Research; Vol. 10, iss. 1
Udgivet: (2020)

Блокирование свободных функциональных групп как метод управления цитотоксичностью алкоксиаминов; Химия и химическая технология в XXI веке; Т. 1
af: Колесникова Ю. А.
Udgivet: (2024)

HER2-Specific Pseudomonas Exotoxin A PE25 Based Fusions: Influence of Targeting Domain on Target Binding, Toxicity, and In Vivo Biodistribution; Pharmaceutics; Vol. 12, iss. 4
Udgivet: (2020)

Comparative Preclinical Evaluation of HYNIC-Modified Designed Ankyrin Repeat Proteins G3 for the 99mTc-Based Imaging of HER2-Expressing Malignant Tumors; Molecular Pharmaceutics; Vol. 21, iss. 4
Udgivet: (2024)

Preclinical Evaluation of the GRPR-Targeting Antagonist RM26 Conjugated to the Albumin-Binding Domain for GRPR-Targeting Therapy of Cancer; Pharmaceutics; Vol. 12, iss. 10
Udgivet: (2020)

Metal-Organic Frameworks (MOFs) for Cancer Therapy; Materials; Vol. 14, iss. 23
Udgivet: (2021)

Synthetic approaches to the preparation of natural acyl aryl glycosides; Химия и химическая технология в XXI веке; Т. 2
af: Avetian D. L. David Ludvigovich
Udgivet: (2021)

Half-life extension via ABD-fusion leads to higher tumor uptake of an affibody-drug conjugate compared to PAS- and XTENylation; Journal of Controlled Release; Vol. 370
Udgivet: (2024)

Cancer Therapeutic Targets
Udgivet: (2016)

Influence of SBRT fractionation on TCP and NTCP estimations for prostate cancer; Physica Medica; Vol. 62
Udgivet: (2019)

2-(2-(Fluorosulfonyloxy)phenyl)benzoxazole; Molbank; Vol. 2021, iss. 3
af: Danilenko N. V. Nadezhda Viktorovna
Udgivet: (2021)

Разработка многоагентных систем распределенного решения энергетических задач с использованием агентных сценариев; Известия Томского политехнического университета [Известия ТПУ]; Т. 326, № 5
af: Массель Л. В. Людмила Васильевна
Udgivet: (2015)

Development of Bulk Lightweight Spherosilicate Material Technology Based on Sublimation of Expanded Polystyrene Granules; Refractories and Industrial Ceramics; Vol. 60, iss. 5
af: Nizhegorodov A. I. Anatoliy Ivanovich
Udgivet: (2020)

Dosimetric and radiobiological comparison of simultaneous integrated boost and sequential boost of locally advanced cervical cancer; Physica Medica; Vol. 73
Udgivet: (2020)

Нанотехнологии в биологии и медицине: учебное пособие
af: Артюхов В. Г. Валерий Григорьевич
Udgivet: (Москва, Кнорус, 2025)

Estimation of treatment efficiency of head-and-neck cancer based on tumour control probability model; South Florida Journal of Development; Vol. 4, iss. 1
Udgivet: (2023)

Сложные эфиры феруловой кислоты: выделение, новые подходы к синтезу и оценка биологической активности: автореферат диссертации на соискание ученой степени кандидата химических наук; спец. 02.00.03
af: Бахолдина Л. А. Любовь Алексеевна
Udgivet: (Томск, [Б. и.], 2018)

Influence of Residualizing Properties of the Radiolabel on Radionuclide Molecular Imaging of HER3 Using Affibody Molecules; International Journal of Molecular Sciences; Vol. 21, iss. 4
Udgivet: (2020)

Benefit of Later-Time-Point PET Imaging of HER3 Expression Using Optimized Radiocobalt-Labeled Affibody Molecules; International Journal of Molecular Sciences; Vol. 21, iss. 6
Udgivet: (2020)

Сложные эфиры феруловой кислоты: выделение, новые подходы к синтезу и оценка биологической активности: диссертация на соискание ученой степени кандидата химических наук; спец. 02.00.03
af: Бахолдина Л. А. Любовь Алексеевна
Udgivet: (Бийск, [Б. и.], 2018)

Digital Inclusion of Individuals with Autism Spectrum Disorder
af: Glumbić, Nenad, et al.
Udgivet: (2022)